Pharmaceutics Webinar | Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines
Pharmaceutics Webinar | Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines
Part of the Pharmaceutics Webinar series
17 December 2025
Pharmacy, Personalized, Formulation, Pharmaceutical, Compounding, Extemporaneous
Welcome from the Chair
5th Pharmaceutics Webinar
Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines
Dear colleagues,
It is my pleasure to invite you to the upcoming webinar dedicated to Extemporaneous Pharmaceutical Formulations and Personalized Medicines. This event will bring together distinguished experts and practitioners to discuss the evolving role of customised medications within modern healthcare.
Extemporaneous formulations embody the true essence of personalised medicine — allowing for tailored treatments that respond to specific patient needs when industrially manufactured products are unavailable or unsuitable. Recent advances in compounding technologies, materials, and regulatory approaches have strengthened the scientific foundation of these preparations, ensuring higher standards of quality, safety, and reproducibility.
At the same time, this field continues to face important challenges — from standardisation and scalability to ensuring consistent therapeutic outcomes. Through this webinar, we aim to explore how innovation, collaboration, and patient-centred thinking can transform these challenges into opportunities for growth and global health improvement.
I warmly thank our invited speakers, Professor Milap Nahata from the Ohio State University, Doctor Karolina Dziemidowicz from the University College of London, and Professor Antonio Lopalco from the University of Bari Aldo Moro, for sharing their expertise and insights, and all those who will participate by joining us in the discussion. I hope this session will inspire new ideas, collaborations, and future developments in the field of pharmaceutical compounding.
Thank you for being with us, and I wish you all an engaging and fruitful webinar.
Date: 17 December 2025
Time: 4:00 p.m. CET | 10:00 a.m. EST
Webinar ID: 851 6540 3655
Webinar Secretariat: journal.webinar@mdpi.com
Event Chair
Department of Pharmacy, Pharmaceutical Sciences, University of Bari Aldo Moro, Italy
Nunzio Denora received a degree in Pharmaceutical Chemistry and Technology at the University of Bari in 2001 and achieved his Ph.D. in Pharmaceutical Technology at the University of Palermo in 2004. After a postdoctoral position at the Pharmaceutical Chemistry Department of Kansas University, US (2005-2006), he was appointed as an assistant professor and research scientist of Pharmaceutical Technology at the Department of Pharmacy - Pharmaceutical Sciences of the University of Bari “Aldo Moro”. Since 2024, he has been a full professor of Pharmaceutical Technology heading a formulation research laboratory focusing on advanced drug delivery systems. He has published more than 220 research articles and is the inventor of 10 patents concerning formulations and diagnostic probes. Since 2016, he has been the head of the Inter-University Consortium CIRCSMB research group of Bari (> 30 scientists) and serves as Scientific Advisor for pharmaceutical companies. He is a member of the Board SITELF Italy Chapter and an advisory board member for different journals in the field of pharmaceutics. He is a member of the scientific committee of the European Paedriatric Translational Research Infrastructure EPTRI. His research is devoted to the development of paediatric formulations through conventional and innovative techniques.
Invited Speakers
Pediatrics and Internal Medicine at the College of Medicine, Ohio State University, USA
Doctor Milap C. Nahata is the Founding Director of the Institute of Therapeutic Innovations and Outcomes (ITIO) and Professor Emeritus of Pharmacy, Pediatrics, and Internal Medicine at The Ohio State University (OSU). He began his academic career at OSU in 1977 and served as Chair of the Division of Pharmacy Practice and Science (1998–2013), leading nationally recognized advancements in clinical pharmacy education, research, and practice. An internationally respected educator, he has taught over 6,000 pharmacy students and mentored more than 200 residents, fellows, and graduate students. Dr. Nahata has received numerous national teaching and research awards, including the Remington Honor Medal, Harvey Whitney Lecture Award, AACP Lifetime Achievement Award, and Sumner Yaffe Lifetime Achievement Award in Pediatric Pharmacology. He has authored or coauthored nearly 700 scientific publications and five books, served as Editor-in-Chief of The Annals of Pharmacotherapy since 2006, and delivered over 400 invited lectures worldwide. Dr. Nahata is a Fellow of seven major scientific and professional societies, a lifetime member of the U.S. National Academy of Medicine, and a past President of both AACP and ACCP. Through ITIO, he continues to advance medication therapy management and patient-centered pharmacotherapy nationwide.
Pharmacy, Pediatrics, & amp; Internal Medicine, Unit / Department / Division Pharmacy, Practice and Science
Dr Karolina Dziemidowicz is a Lecturer in Pharmaceutics and a practising pharmacist. She obtained her MPharm degree from King's College London in 2015. During her undergraduate studies, Karolina undertook her MPharm dissertation at Utrecht University (Pharmaceutics Department). She completed her Pharmacist foundation training at AstraZeneca (Macclesfield, UK) and Manchester University hospital. Afterwards, she joined UCL for a PhD studentship within the CDT in Advanced Therapeutics and Nanomedicines, where she worked on antibody-functionalised biomaterials for cancer immunotherapy. Shortly after obtaining her PhD, she moved to the Centre for Nerve Engineering for a one-year postdoctoral project on the preclinical testing of drug-eluting biomaterials for peripheral nerve injury. In 2021, she was awarded an EPSRC Doctoral Prize individual fellowship to work on designing neuroprotective biomaterials for dura regeneration following spinal cord injury. She established her own research group in 2022.
Electrospinning; Encapsulation; Nanocarrier; Nanofiber; Target Drug Delivery; Spinal Cord Injury; Biomaterials; Neural Tissue Engineering; Immunotherapy; Cancer Immunotherapy; Protein Drug Delivery; Antibody Delivery; Surface Functionalization
Department of Pharmacy, Pharmaceutical Sciences, University of Bari Aldo Moro, Italy
Antonio Lopalco holds a master’s degree in Chemistry and Pharmaceutical Technology from the University of Bari in 2008 and a Ph.D. in Pharmaceutical Technology from the University of Palermo in 2012. After completing postdoctoral work in Pharmaceutical Chemistry at the University of Kansas, he was appointed to associate researcher in that Department in 2015. He joined the faculty of the Department of Pharmacy – Pharmaceutical Sciences at the University of Bari Aldo Moro in 2016 and worked his way up through the academic ranks to become an Associate Professor in 2019. Doctor Lopalco’ research interests have included the development of innovative drug delivery systems, age-related formulations and extemporaneous formulations. Dr. Lopalco is the author or co-author of more than 85 research articles and 5 patents. He serves as a reviewer for several international scientific journals and is a member of the Editorial Board of the Journal of Pharmaceutical Sciences (Elsevier) and Pharmaceutics (MDPI).
Drug Delivery; Age Related Formulation; Nanomedicine; Pharmaceutical Technology
Registration
This is a FREE webinar. After registering, you will receive a confirmation email containing information on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Certificates of attendance will be delivered to those who attend the live webinar.
Can’t attend? Register anyway and we’ll let you know when the recording is available to watch.
Program
|
Speaker/Presentation |
Time in EST |
Time in CET |
|
Chair Introduction Prof. Dr. Nunzio Denora |
10:00 - 10:10 am |
4:00 - 4:10 pm |
|
Extemporaneous Formulations for Pediatric Patients: Global Necessities and Challenges Prof. Dr. Milap C. Nahata |
10:10 - 10:30 am |
4:10 - 4:30 pm |
|
OrPhyllo™ Orodispersible Films: In Vitro Characterisation and Human Sensory Insights Dr. Karolina Dziemidowicz |
10:30 - 10:50 am |
4:30 - 4:50 pm |
|
3D Printing by Direct Powder Extrusion: A New Frontier in Personalized Pharmacy Compounding Dr. Antonio Lopalco |
10:50 - 11:10 am |
4:50 - 5:10 pm |
|
Q&A |
11:10 - 11:25 am |
5:10 - 5:25 pm |
|
Closing of Webinar Prof. Dr. Nunzio Denora |
11:25 - 11:30 am |
5:25 - 5:30 pm |
Relevant Special Issue
Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines, 2nd Edition
Edited by: Dr. Antonio Lopalco and Prof. Dr. Nunzio Denora
Deadline for submission: 31 May 2026
Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines
Edited by: Dr. Antonio Lopalco and Prof. Dr. Nunzio Denora
Sponsors and Partners
Organizers
